Robin Pashby

We're at a point where we need to hold two truths.

that GLP-1s are legitimate evidence-based treatments for obesity, but that they also sit inside our culture, which has intense weight pressure, weight stigma, and eating disorder risk.

We're at a point where we need to hold two truths.

that GLP-1s are legitimate evidence-based treatments for obesity, but that they also sit inside our culture, which has intense weight pressure, weight stigma, and eating disorder risk.

will develop a clinical eating disorder over their lifetime.

And even more have problem relationships with eating or weight, binging or restricting food, for example.

Washington, D.C.

psychologist Robin Pashby says, especially when people acquire GLP-1 drugs online, they are not screened for eating disorders.